Literature DB >> 33389283

LncRNA FTX Promotes Colorectal Cancer Cells Migration and Invasion by miRNA-590-5p/RBPJ Axis.

Guo-Qun Chen1, Zhi-Ming Liao1, Jiao Liu1, Fang Li1, Da Huang1, Ya-Dong Zhou2.   

Abstract

Colorectal cancer (CRC) is one of the most lethal human cancers all over the world. Moreover, it ranks fourth for cancer-related deaths among males. Although many efforts have been made to cure CRC, the effect remains limited. It has been reported that lncRNA five prime to Xist (FTX) was upregulated in CRC. However, the mechanism by which lncRNA FTX regulates the progression of CRC remains largely unknown. In this study, qRT-PCR was performed to detect the expression of FTX, miR-590-5p and Recombination signal binding protein for immunoglobulin kappa J region (RBPJ) in CRC tissues or cells. Protein expression in cells was measured by western blot. MTT assay was used to test the cell viability. Moreover, transwell was performed to examine the cell migration and invasion. Luciferase report assay was performed to verify the relation between miR-590-5p and FTX or RBPJ. It was found that FTX was upregulated in CRC tissues and cells. Knockdown of FTX or overexpression of miR-590-5p can inhibit the proliferation, migration, and invasion of CRC cells. Besides, silencing of FTX could inhibit the expression of migration and invasion-related proteins in CRC cells. Meanwhile, miR-590-5p was the target of FTX, and RBPJ was the direct target of miR-590-5p. Inhibition of miR-590-5p could reverse the inhibitory effect of FTX on the progression of CRC. These findings suggested that knockdown of FTX could inhibit the tumorigenesis of CRC in vitro, which may serve as a potential novel strategy for treatment of CRC.

Entities:  

Keywords:  Colorectal cancer; Invasion; LncRNA FTX; Migration; RBPJ; miRNA-590-5p

Mesh:

Substances:

Year:  2021        PMID: 33389283     DOI: 10.1007/s10528-020-10017-8

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  1 in total

1.  Expression of EMT Markers SLUG and TWIST in Breast Cancer.

Authors:  Jedrzej Grzegrzolka; Martyna Biala; Patrycja Wojtyra; Christopher Kobierzycki; Mateusz Olbromski; Agnieszka Gomulkiewicz; Aleksandra Piotrowska; Janusz Rys; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

  1 in total
  10 in total

1.  FTX Regulated miR-153-3p/FOXR2 to Promote Cisplatin Resistance in Ovarian Cancer.

Authors:  Ming Liu; Jingwei Peng
Journal:  Comput Math Methods Med       Date:  2022-05-23       Impact factor: 2.809

2.  Potential Value of Circular RNA circTBC1D4 in Gastrointestinal Stromal Tumors.

Authors: 
Journal:  J Immunol Res       Date:  2022-05-24       Impact factor: 4.493

3.  LncRNA Expression Profiles in Canine Mammary Tumors Identify lnc34977 as a Promoter of Proliferation, Migration and Invasion of Canine Mammary Tumor Cells.

Authors:  Baochun Lu; Juye Wu; Hebi Chen; Shoujun Li; Kun Jia
Journal:  Vet Sci       Date:  2022-02-15

4.  Shikonin induces cell autophagy via modulating the microRNA -545-3p/guanine nucleotide binding protein beta polypeptide 1 axis, thereby disrupting cellular carcinogenesis in colon cancer.

Authors:  ZhiWei Hu; XinDong Zhou; DeQiang Zeng; JiaJun Lai
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

5.  Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma.

Authors:  Tao Wei; Ning Zhu; Weihua Jiang; Xiao-Liang Xing
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

6.  Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma.

Authors:  Hua Liu; Chenyu Zong; Jiacheng Sun; Haiyang Li; Guangzhen Qin; Xiaojian Wang; Jianwei Zhu; Yang Yang; Qiang Xue; Xianchen Liu
Journal:  Transl Pediatr       Date:  2022-07

7.  Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors.

Authors:  Qing Li; Yonghao Li; Ximei Sun; Xinlei Zhang; Mei Zhang
Journal:  Int J Endocrinol       Date:  2022-07-16       Impact factor: 2.803

8.  A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer.

Authors:  Dong Hou; Jia-Nan Tan; Sheng-Ning Zhou; Xu Yang; Zhi-Hong Zhang; Guang-Yu Zhong; Lin Zhong; Bin Yang; Fang-Hai Han
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

Review 9.  The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation.

Authors:  Chiara Siniscalchi; Armando Di Palo; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

10.  Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis.

Authors:  Xiaolei Wang; Yu Su; Chuangao Yin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.